Update on novel hormonal and nonhormonal male contraceptive development
JE Long, MS Lee, DL Blithe - The Journal of Clinical …, 2021 - academic.oup.com
Background The advent of new methods of male contraception would increase
contraceptive options for men and women and advance male contraceptive agency …
contraceptive options for men and women and advance male contraceptive agency …
Nonhormonal male contraceptive development—strategies for progress
L Nickels, W Yan - Pharmacological Reviews, 2024 - ASPET
Despite the widely demonstrated public health benefits of contraception, limited
contraceptive options are available for men, placing both the contraceptive burden and …
contraceptive options are available for men, placing both the contraceptive burden and …
Hormonal male contraception: getting to market
ST Page, D Blithe, C Wang - Frontiers in endocrinology, 2022 - frontiersin.org
Rates of unplanned pregnancies are high and stagnant globally, burdening women, families
and the environment. Local limitations placed upon contraceptive access and abortion …
and the environment. Local limitations placed upon contraceptive access and abortion …
Interactions of the male contraceptive target EPPIN with semenogelin-1 and small organic ligands
AAS Gomes, NCM Santos, LR Rosa, RJ Borges… - Scientific reports, 2023 - nature.com
Novel male contraceptives will promote gender equality in sharing contraceptive
responsibility. The sperm-associated protein epididymal protease inhibitor (EPPIN) is a …
responsibility. The sperm-associated protein epididymal protease inhibitor (EPPIN) is a …
[HTML][HTML] Focus: Sex & Reproduction: Male Contraception
Unintended pregnancy is a global public health problem. Despite a variety of female
contraceptive options, male contraceptive options are limited to the condom and vasectomy …
contraceptive options, male contraceptive options are limited to the condom and vasectomy …
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial
Objective To determine men's satisfaction with and the potential acceptability of 11β-methyl-
19-nortestosterone dodecylcarbonate (11β-MNTDC) when used for 28 days as an …
19-nortestosterone dodecylcarbonate (11β-MNTDC) when used for 28 days as an …
[HTML][HTML] The future of male contraception: a fertile ground
I Khourdaji, J Zillioux, K Eisenfrats… - … andrology and urology, 2018 - ncbi.nlm.nih.gov
The continued and rapid expansion of the Earth's population mandates the need for safe
and effective measures of contraception. While a plethora of options exist for women …
and effective measures of contraception. While a plethora of options exist for women …
[HTML][HTML] A long way to go: engagement of men and boys in country family planning commitments and implementation plans
C Hook, K Hardee, T Shand, S Jordan… - Gates Open …, 2021 - ncbi.nlm.nih.gov
Background: To reach global goals related to women and girls' access to modern family
planning (FP) and gender equality, evidence shows that it is critical to understand and …
planning (FP) and gender equality, evidence shows that it is critical to understand and …
[HTML][HTML] What about methods for men? A qualitative analysis of attitudes toward male contraception in Burkina Faso and Uganda
AF Cartwright, A Lawton, A Brunie… - … perspectives on sexual …, 2020 - ncbi.nlm.nih.gov
METHODS: Qualitative data were taken from focus group discussions with 80 men aged 23-
67 and 398 women aged 15-50 that were conducted in Burkina Faso and Uganda in 2016 …
67 and 398 women aged 15-50 that were conducted in Burkina Faso and Uganda in 2016 …
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype
BT Nguyen, MT Farrant, BD Anawalt, F Yuen… - Contraception, 2020 - Elsevier
Objective To determine men's satisfaction with and acceptability of a once-daily, oral
regimen of dimethandrolone undecanoate (DMAU) versus placebo when used for 28 days …
regimen of dimethandrolone undecanoate (DMAU) versus placebo when used for 28 days …